Newspaper publication of Standalone and Consolidated Un-audited Financial Results for Quarter and Nine month ended 31st December 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shukra Pharmaceuticals Ltd has informed BSE that its Standalone and Consolidated Un-audited Financial Results for the quarter and nine months ended December 31, 2025 were published in two newspapers — Business Standard (English) and Jai Hind (Gujarati) — on February 5, 2026. This publication has been carried out as required under Regulation 47 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The letter is signed by Director Ritu Kapoor (DIN: 10334249). The actual financial numbers themselves are not part of this filing; this is only a confirmation that the previously filed results were published in newspapers for public information.
This is a routine regulatory compliance filing and does not contain any new financial information. Shareholders who want the actual Q3 numbers should refer to the earlier results filing already submitted to the stock exchange. No material impact on the stock price is expected from this disclosure.